CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
01 juin 2024 05h36 HE
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
28 mai 2024 07h26 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie, Inc. If...
CERE (NASDAQ) ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation; Contact BFA Law to Discuss Your Rights
25 mai 2024 05h18 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie, Inc. If...
BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by AbbVie, Contact the Firm for Details
21 mai 2024 06h38 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If you invested in...
INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerevel Therapeutics and AbbVie for Unfair Process
17 mai 2024 07h12 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- If you invested in Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) you are encouraged to obtain additional information by visiting...
CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough? Bleichmar Fonti & Auld LLP is Currently Investigating the Acquisition
14 mai 2024 08h33 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- If you invested in Cerevel Therapeutics Holdings, Inc. you are encouraged to obtain additional information by contacting Ross Shikowitz at ross@bfalaw.com,...